Suppr超能文献

转化再生医学蓝图。

A blueprint for translational regenerative medicine.

作者信息

Armstrong James P K, Keane Timothy J, Roques Anne C, Patrick P Stephen, Mooney Claire M, Kuan Wei-Li, Pisupati Venkat, Oreffo Richard O C, Stuckey Daniel J, Watt Fiona M, Forbes Stuart J, Barker Roger A, Stevens Molly M

机构信息

Department of Materials, Imperial College London, London SW7 2AZ, UK.

Department of Bioengineering, Imperial College London, London SW7 2AZ, UK.

出版信息

Sci Transl Med. 2020 Dec 2;12(572). doi: 10.1126/scitranslmed.aaz2253.

Abstract

The past few decades have produced a large number of proof-of-concept studies in regenerative medicine. However, the route to clinical adoption is fraught with technical and translational obstacles that frequently consign promising academic solutions to the so-called "valley of death." Here, we present a proposed blueprint for translational regenerative medicine. We offer principles to help guide the selection of cells and materials, present key in vivo imaging modalities, and argue that the host immune response should be considered throughout design and development. Last, we suggest a pathway to navigate the often complex regulatory and manufacturing landscape of translational regenerative medicine.

摘要

在过去几十年里,再生医学领域开展了大量概念验证研究。然而,临床应用之路充满了技术和转化障碍,这些障碍常常使有前景的学术解决方案陷入所谓的“死亡谷”。在此,我们提出了一份转化性再生医学的蓝图。我们提供了有助于指导细胞和材料选择的原则,介绍了关键的体内成像模式,并认为在整个设计和开发过程中都应考虑宿主免疫反应。最后,我们提出了一条途径,以应对转化性再生医学中通常复杂的监管和制造局面。

相似文献

1
A blueprint for translational regenerative medicine.
Sci Transl Med. 2020 Dec 2;12(572). doi: 10.1126/scitranslmed.aaz2253.
2
Regenerative Medicine Build-Out.
Stem Cells Transl Med. 2015 Dec;4(12):1373-9. doi: 10.5966/sctm.2015-0275. Epub 2015 Nov 4.
3
Prospects for translational regenerative medicine.
Biotechnol Adv. 2012 May-Jun;30(3):658-72. doi: 10.1016/j.biotechadv.2011.11.005. Epub 2011 Nov 27.
4
The Progression of Regenerative Medicine and its Impact on Therapy Translation.
Clin Transl Sci. 2020 May;13(3):440-450. doi: 10.1111/cts.12736. Epub 2020 Feb 6.
5
Value-engineered translation for regenerative medicine: meeting the needs of health systems.
Stem Cells Dev. 2013 Dec;22 Suppl 1(Suppl 1):89-93. doi: 10.1089/scd.2013.0398.
6
Engineering Functional Cardiac Tissues for Regenerative Medicine Applications.
Curr Cardiol Rep. 2019 Aug 1;21(9):105. doi: 10.1007/s11886-019-1178-9.
7
Regenerative medicine: looking backward 10 years further on.
Regen Med. 2016 Dec;11(8):787-800. doi: 10.2217/rme-2016-0136. Epub 2016 Nov 25.
8
Are there specific translational challenges in regenerative medicine? Lessons from other fields.
Regen Med. 2015;10(7):885-95. doi: 10.2217/rme.15.50. Epub 2015 Nov 6.
9
10
Regenerative medicine: challenges and opportunities.
Lancet. 2020 Jun 6;395(10239):1746-1747. doi: 10.1016/S0140-6736(20)31250-2.

引用本文的文献

1
Hypoxia-induced metabolic reprogramming in mesenchymal stem cells: unlocking the regenerative potential of secreted factors.
Front Cell Dev Biol. 2025 Jun 9;13:1609082. doi: 10.3389/fcell.2025.1609082. eCollection 2025.
2
analysis of hybrid hydrogels containing dual growth factor combinations, and skeletal stem cells under mechanical stimulation for bone repair.
Mechanobiol Med. 2024 Aug 27;2(4):100096. doi: 10.1016/j.mbm.2024.100096. eCollection 2024 Dec.
3
Self-Healing Hydrogels: Mechanisms and Biomedical Applications.
MedComm (2020). 2025 Apr 24;6(5):e70181. doi: 10.1002/mco2.70181. eCollection 2025 May.
4
An overview of stem cells and cell products involved in trauma injury.
Regen Ther. 2025 Mar 11;29:60-76. doi: 10.1016/j.reth.2025.02.011. eCollection 2025 Jun.
5
Nanoparticle Contrast Agents for Dark-Field X-ray Imaging.
Nano Lett. 2025 Jan 22;25(3):1036-1042. doi: 10.1021/acs.nanolett.4c04878. Epub 2024 Nov 27.
6
Modelling and targeting mechanical forces in organ fibrosis.
Nat Rev Bioeng. 2024 Apr;2(4):305-323. doi: 10.1038/s44222-023-00144-3. Epub 2024 Jan 18.
7
Fostering tissue engineering and regenerative medicine to treat musculoskeletal disorders in bone and muscle.
Bioact Mater. 2024 Jun 15;40:345-365. doi: 10.1016/j.bioactmat.2024.06.022. eCollection 2024 Oct.
8
CT-Visible Microspheres Enable Whole-Body In Vivo Tracking of Injectable Tissue Engineering Scaffolds.
Adv Healthc Mater. 2024 Jul;13(17):e2303588. doi: 10.1002/adhm.202303588. Epub 2024 May 4.
9
Clinical translation of pluripotent stem cell-based therapies: successes and challenges.
Development. 2024 Apr 1;151(7). doi: 10.1242/dev.202067. Epub 2024 Apr 2.
10
Sticky gels designed for tissue-healing therapies and diagnostics.
Nature. 2024 Jan;625(7995):455-457. doi: 10.1038/d41586-023-03996-2.

本文引用的文献

1
Woman is first to receive cornea made from 'reprogrammed' stem cells.
Nature. 2019 Sep 2. doi: 10.1038/d41586-019-02597-2.
2
Safety profile of autologous macrophage therapy for liver cirrhosis.
Nat Med. 2019 Oct;25(10):1560-1565. doi: 10.1038/s41591-019-0599-8. Epub 2019 Oct 7.
3
4D functional ultrasound imaging of whole-brain activity in rodents.
Nat Methods. 2019 Oct;16(10):994-997. doi: 10.1038/s41592-019-0572-y. Epub 2019 Sep 23.
7
In vivo label-free functional photoacoustic monitoring of ischemic reperfusion.
J Biophotonics. 2019 Jul;12(7):e201800454. doi: 10.1002/jbio.201800454. Epub 2019 Apr 1.
8
Buoyancy-Driven Gradients for Biomaterial Fabrication and Tissue Engineering.
Adv Mater. 2019 Apr;31(17):e1900291. doi: 10.1002/adma.201900291. Epub 2019 Mar 7.
9
Emerging Technologies for Tissue Engineering: From Gene Editing to Personalized Medicine.
Tissue Eng Part A. 2019 May;25(9-10):688-692. doi: 10.1089/ten.TEA.2019.0026.
10
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
Nat Biotechnol. 2019 Mar;37(3):252-258. doi: 10.1038/s41587-019-0016-3. Epub 2019 Feb 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验